PC
BEAT

Palo Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Palo Capital’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-14,378
Closed -$168K – 258
2016
Q1 		$168K Buy
+14,378
New +$161K 0.13% 161

Other funds holding BEAT

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Palo Capital's BEAT Position: Q2 2016 in Review

Palo Capital sold out of BioTelemetry, Inc. (BEAT) in Q2 2016, closing a stake of 14,378 shares — an estimated $168K sold.

Palo Capital first reported a position in BEAT in Q1 2016 and held it in 1 quarter. The position peaked at $168K in Q1 2016. 139 funds tracked by Wall St. Rank hold BEAT as of Q2 2016.

  • Palo Capital reported no remaining BioTelemetry, Inc. position as of Q2 2016 after selling out during the quarter.
  • Palo Capital sold 14,378 BioTelemetry, Inc. shares in Q2 2016, an estimated $168K.
  • Palo Capital first reported a position in BioTelemetry, Inc. in Q1 2016 and held it in 1 quarter.
  • Palo Capital's BioTelemetry, Inc. position peaked at $168K in Q1 2016.
  • 139 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2016.

Based on Palo Capital's 13F filing for Q2 2016, filed 20 Jul 2016.